TrianglePUBLICATIONS · 25695691
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2015 Jun 15
- First author
- DuBois SG
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- DuBois SG
- type
- Author
- name
- Groshen S
- type
- Author
- name
- Park JR
- type
- Author
- name
- Haas-Kogan DA
- type
- Author
- name
- Yang X
- type
- Author
- name
- Geier E
- type
- Author
- name
- Chen E
- type
- Author
- name
- Giacomini K
- type
- Author
- name
- Weiss B
- type
- Author
- name
- Cohn SL
- type
- Author
- name
- Granger MM
- type
- Author
- name
- Yanik GA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- DuBois SG
- type
- Author
- name
- Groshen S
- type
- Author
- name
- Park JR
- type
- Author
- name
- Haas-Kogan DA
- type
- Author
- name
- Yang X
- type
- Author
- name
- Geier E
- type
- Author
- name
- Chen E
- type
- Author
- name
- Giacomini K
- type
- Author
- name
- Weiss B
- type
- Author
- name
- Cohn SL
- type
- Author
- name
- Granger MM
- type
- Author
- name
- Yanik GA
- type
- Author
- bibliography ids
- nci-bib-59644263aab86a06c228616a
- book metadata
- content sha256
- e8afc108f2c7c80c12b977b930f74452830df743a582fbf2c35de80d28e65e67
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-14-3240
- electronic publication date
- display
- 2015 Feb 18
- precision
- day
- year
- 2015
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:25695691
- immutable id
- pubmed:25695691@e8afc108f2c7c80c12b977b930f74452830df743a582fbf2c35de80d28e65e67
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- 1557-3265
- issn print
- 1078-0432
- issue
- 12
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 2715-21
- volume
- 21
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 25695691
- provenance
- batch id
- 74265f1b641f04cf2d05
- provider
- NCBI PubMed ESummary
- record sha256
- 79067eac991b74a033b5cdb2ff9e5f544b3b17ef48e6cc4906ec20f60f6ca015
- response sha256
- 193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
- retrieved at
- 2026-09-09T23:47:10.134322+00:00
- publication date
- display
- 2015 Jun 15
- precision
- day
- year
- 2015
- publication types
- Clinical Trial, Phase I
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.
Preserved source evidence · Not medical advice